1. Home
  2. ODP vs AKBA Comparison

ODP vs AKBA Comparison

Compare ODP & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODP
  • AKBA
  • Stock Information
  • Founded
  • ODP 1986
  • AKBA 2007
  • Country
  • ODP United States
  • AKBA United States
  • Employees
  • ODP N/A
  • AKBA N/A
  • Industry
  • ODP Other Specialty Stores
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODP Consumer Discretionary
  • AKBA Health Care
  • Exchange
  • ODP Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ODP 834.9M
  • AKBA 729.1M
  • IPO Year
  • ODP N/A
  • AKBA 2014
  • Fundamental
  • Price
  • ODP $27.88
  • AKBA $2.21
  • Analyst Decision
  • ODP Hold
  • AKBA Strong Buy
  • Analyst Count
  • ODP 1
  • AKBA 6
  • Target Price
  • ODP $19.00
  • AKBA $6.25
  • AVG Volume (30 Days)
  • ODP 1.0M
  • AKBA 4.5M
  • Earning Date
  • ODP 11-05-2025
  • AKBA 11-10-2025
  • Dividend Yield
  • ODP N/A
  • AKBA N/A
  • EPS Growth
  • ODP N/A
  • AKBA N/A
  • EPS
  • ODP 0.84
  • AKBA N/A
  • Revenue
  • ODP $6,690,000,000.00
  • AKBA $203,733,000.00
  • Revenue This Year
  • ODP N/A
  • AKBA $43.91
  • Revenue Next Year
  • ODP N/A
  • AKBA $32.09
  • P/E Ratio
  • ODP $17.29
  • AKBA N/A
  • Revenue Growth
  • ODP N/A
  • AKBA 16.75
  • 52 Week Low
  • ODP $11.85
  • AKBA $1.52
  • 52 Week High
  • ODP $32.21
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ODP 69.49
  • AKBA 32.27
  • Support Level
  • ODP $27.76
  • AKBA $2.07
  • Resistance Level
  • ODP $27.84
  • AKBA $3.19
  • Average True Range (ATR)
  • ODP 0.09
  • AKBA 0.17
  • MACD
  • ODP -0.22
  • AKBA -0.09
  • Stochastic Oscillator
  • ODP 69.27
  • AKBA 12.95

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue stems from the Veyer division.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: